Roche launches Hemlibra in India
India, April 17 -- Roche announced that Emicizumab (Hemlibra) has been approved in India for Haemophilia A with factor VIII inhibitors. It is indicated as a prophylactic(preventive) treatment to prevent or reduce the frequency of bleeding episodes. Hemlibra is the first weekly subcutaneous (under the skin) prophylaxis injection shown to prevent or reduce the frequency of bleeding episodes and improve the quality of life. It is designed to bring together factor IXa and factor X proteins required to activate the natural coagulation cascade and restore the blood clotting process for people with Haemophilia A.
All current prophylactic treatment options for people with Haemophilia A with factor VIII inhibitors require intravenous infusions se...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.